<DOC>
<DOCNO>
EP-0004794
</DOCNO>
<TEXT>
<DATE>
19791017
</DATE>
<IPC-CLASSIFICATIONS>
A61K-31/55 C07D-491/00 C07D-319/00 C07C-41/00 C07C-45/63 C07C-45/00 C07D-491/04 C07D-319/18 C07C-43/225 C07D-223/00 C07C-43/00 C07C-41/26 C07C-43/23 <main>C07D-223/16</main> C07C-43/205 A61P-25/00 A61P-9/00 A61P-9/12 C07D-223/16 C07C-45/71 A61P-43/00 
</IPC-CLASSIFICATIONS>
<TITLE>
substituted benzazepines, processes for preparing them and pharmaceutical compositions containing them.
</TITLE>
<APPLICANT>
smithkline corpus<sep>smithkline corporation<sep>smithkline beckman corporationp.o. box 7929 1 franklin plazaphiladelphia pennsylvania 19101us<sep>smithkline beckman corporation<sep>
</APPLICANT>
<INVENTOR>
weinstock joseph<sep>weinstock, joseph<sep>weinstock, joseph1234 pothouse roadphoenixville pennsylvania 19405us<sep>weinstock, joseph<sep>weinstock, joseph1234 pothouse roadphoenixville pennsylvania 19405us<sep>
</INVENTOR>
<ABSTRACT>
a group of 6,9-disubstituted-7,8-dihydroxy-1-phenyl-  2,3,4,5-tetrahydro-1h-3-benzazepine have dopaminergic  activity.  examples of compounds of the invention are  9-chloro-7,8-dihydroxy-1-(p-hydroxyphenyl)-6-methyl-  2,3,4,5-tetrahydro-1h-3-benzazepine and 6,9-dichloro-7,8-  dihydroxy-1-(p-hydroxyphenyl)-2,3,4,5-tetrahydro-1h-3-  benzazepine, preferably in the form of an acid addition salt  thereof, have antihypertensive activity.  
</ABSTRACT>
</TEXT>
</DOC>
